Presentation THT 2024 AAV9 Expression of Junctophilin to Treat HF Presenter: Long-Sheng Song March 05, 2024 REGISTER for free or LOG IN to view this content Heart Failure THT 2024 Up Next Presentation THT 2024 Novel Strategies in mRNA Therapeutics for Heart Failure Presenter: John Cooke March 05, 2024 More slides + Presentation THT 2024 A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1 Presenter: Lothar Roessig March 05, 2024 Presentation THT 2024 CMR in Genetic Cardiomyopathy Presenter: Chetan Shenoy March 05, 2024 We Recommend Disclosures Nothing to disclose Video Player is loading.Play VideoPlaySkip BackwardSkip ForwardMuteCurrent Time 0:00/Duration 0:00Loaded: 0%0:00Stream Type LIVESeek to live, currently behind liveLIVERemaining Time -0:00 1xPlayback Rate2x1.75x1.5x1.25x1x, selected0.75x0.5xChaptersChaptersDescriptionsdescriptions off, selectedCaptionscaptions settings, opens captions settings dialogcaptions off, selectedAudio TrackPicture-in-PictureFullscreenThis is a modal window.Beginning of dialog window. Escape will cancel and close the window.TextColorWhiteBlackRedGreenBlueYellowMagentaCyanOpacityOpaqueSemi-TransparentText BackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanOpacityOpaqueSemi-TransparentTransparentCaption Area BackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanOpacityTransparentSemi-TransparentOpaqueFont Size50%75%100%125%150%175%200%300%400%Text Edge StyleNoneRaisedDepressedUniformDrop shadowFont FamilyProportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall CapsResetDoneClose Modal DialogEnd of dialog window.Close Modal DialogThis is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Presentation THT 2024 Novel Strategies in mRNA Therapeutics for Heart Failure Presenter: John Cooke March 05, 2024
Presentation THT 2024 A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1 Presenter: Lothar Roessig March 05, 2024